Core C - Clinical Research and Biorepository

核心 C - 临床研究和生物样本库

基本信息

项目摘要

The Clinical and Repository Core seeks to facilitate the laboratory investigations of all three Consortium projects, while also benefitting from the management of the Administrative Core and providing opportunities for scientific leadership development in collaboration with the Mentorship Core through the following Specific Aims: 1) To recruit, screen, and enroll into research protocols subjects from Ugandan HIV-positive populations with or at risk for AIDS-Defining malignancies; 2) To follow participants prospectively on studies, maintaining close adherence to study procedures; 3) To help maintain a robust biospecimen repository to facilitate the study of the natural history of AIDS-defining malignancies in Uganda and to make these specimens available to the laboratories involved in all three program projects; 4) To facilitate the collection and analysis of data obtained from participants in clinical research studies to allow for the characterization of the clinical, epidemiologic and medical determinants of response to treatment of AIDS-defining malignancies in Uganda. To achieve these aims, the Core will leverage a well-established translational and clinical research infrastructure that has been built by the collaboration between the Hutchinson Center and the Uganda Cancer Institute. A staff of more than 50 individuals who have all been trained in HIV-associated malignancy research and good clinical and laboratory practice work at the collaboration's research clinic in Kampala, which has studied more than 7,000 participants and currently maintains a biorepository with more than 150,000 specimens from patients with HIV and cancer. The Core will support selected staff to provide specimens and data from patients in ongoing prospective cohort studies with or at risk for Kaposi Sarcoma, non-Hodgkin Lymphoma and invasive cervical cancer. At the same time, trainees in clinical research and laboratory science will be integrated into the Core's activities in collaboration with the Mentorship Core to continue to develop a cadre of outstanding Ugandan investigators to lead future studies in HIV-associated malignancies.
临床和知识库核心旨在促进所有三个联盟项目的实验室研究,同时也受益于行政核心的管理,并通过以下具体目标与导师核心合作,为科学领导力发展提供机会:1)从乌干达艾滋病毒阳性人群中招募、筛选和登记患有艾滋病定义的恶性肿瘤或有患艾滋病定义的恶性肿瘤风险的受试者; 2)对参与者进行前瞻性跟踪研究,严格遵守研究程序; 3)帮助维持一个强大的生物标本库,以促进乌干达艾滋病定义恶性肿瘤的自然史研究,并向参与所有三个方案项目的实验室提供这些标本; 4)促进收集和分析从临床研究参与者那里获得的数据,以便能够描述乌干达艾滋病定义恶性肿瘤治疗反应的临床、流行病学和医学决定因素。为了实现这些目标,核心将利用哈钦森中心和乌干达癌症研究所合作建立的完善的转化和临床研究基础设施。在坎帕拉的合作研究诊所工作的50多名工作人员都接受过艾滋病毒相关恶性肿瘤研究以及良好临床和实验室实践的培训,该诊所研究了7 000多名参与者,目前维持着一个生物储存库,其中有15万多份来自艾滋病毒和癌症患者的标本。核心将支持选定的工作人员提供正在进行的前瞻性队列研究中卡波西肉瘤、非霍奇金淋巴瘤和浸润性宫颈癌患者的标本和数据。与此同时,临床研究和实验室科学方面的受训人员将与指导核心小组合作,纳入核心小组的活动,继续培养一支优秀的乌干达研究人员队伍,领导今后与艾滋病毒有关的恶性肿瘤的研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Corey Casper其他文献

Corey Casper的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Corey Casper', 18)}}的其他基金

Scientific Core One
科学核心一
  • 批准号:
    10589643
  • 财政年份:
    2023
  • 资助金额:
    $ 24.38万
  • 项目类别:
HIV integration-mediated modulation of immune regulation in HPV-associated cancers
HIV 整合介导的 HPV 相关癌症免疫调节调节
  • 批准号:
    9982848
  • 财政年份:
    2016
  • 资助金额:
    $ 24.38万
  • 项目类别:
HIV integration-mediated modulation of immune regulation in HPV-associated cancers
HIV 整合介导的 HPV 相关癌症免疫调节调节
  • 批准号:
    9340125
  • 财政年份:
    2016
  • 资助金额:
    $ 24.38万
  • 项目类别:
HIV integration-mediated modulation of immune regulation in HPV-associated cancers
HIV 整合介导的 HPV 相关癌症免疫调节调节
  • 批准号:
    9129244
  • 财政年份:
    2016
  • 资助金额:
    $ 24.38万
  • 项目类别:
HIV integration-mediated modulation of immune regulation in HPV-associated cancers
HIV 整合介导的 HPV 相关癌症免疫调节调节
  • 批准号:
    9767057
  • 财政年份:
    2016
  • 资助金额:
    $ 24.38万
  • 项目类别:
Research Program: Global Oncology
研究项目:全球肿瘤学
  • 批准号:
    9001929
  • 财政年份:
    2015
  • 资助金额:
    $ 24.38万
  • 项目类别:
Research Program: Global Oncology
研究项目:全球肿瘤学
  • 批准号:
    8804796
  • 财政年份:
    2015
  • 资助金额:
    $ 24.38万
  • 项目类别:
Expanding independent research capacity in HIV-associated malignancies in Uganda
扩大乌干达艾滋病毒相关恶性肿瘤的独立研究能力
  • 批准号:
    8708481
  • 财政年份:
    2014
  • 资助金额:
    $ 24.38万
  • 项目类别:
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
乌干达艾滋病定义癌症自然史的生物决定因素
  • 批准号:
    8929189
  • 财政年份:
    2014
  • 资助金额:
    $ 24.38万
  • 项目类别:
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
乌干达艾滋病定义癌症自然史的生物决定因素
  • 批准号:
    8793997
  • 财政年份:
    2014
  • 资助金额:
    $ 24.38万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 24.38万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 24.38万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 24.38万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 24.38万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 24.38万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 24.38万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了